Bill & Melinda Gates FoundationGlobal Grand Challenges
  • Grant Opportunities
  • Challenges
  • Awards
  • Champions
  • Partnerships
  • News
  • About

Human Polyomavirus BKV as a HIV Vaccine Vector

BK virus is a very common and non-pathogenic virus that persists in specific organs for long periods of time. Simon Lacey of Beckman Research Institute of the City of Hope in the U.S. proposes using an engineered BK virus as a vaccine vector to introduce HIV polyepitope sequences in hopes of inducing a strong and long- lasting immune response against HIV.

More information about Create New Ways of Protecting Against Infectious Diseases (Round 2)